COMMUNIQUÉS West-GlobeNewswire

Ventura Cannabis to Acquire Cannabis Dispensary in Oakland, California
10/06/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ALL FIGURES IN CANADIAN DOLLARS UNLESS OTHERWISE SPECIFIED. LOS ANGELES, June 10, 2019 (GLOBE NEWSWIRE) -- Ventura [...]
Wildflower Demand Outpacing Production
10/06/2019
VANCOUVER, British Columbia, June 10, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Wildflower Brands Inc. (CSE: SUN, OTC: WLDFF) (the “ Company ” or “ Wildflower ”) announces that new production facilities are in the [...]
Adverum Biotechnologies Doses First Patient in Second Cohort of OPTIC Phase 1 Clinical Trial of ADVM-022 Gene Therapy for Wet AMD
10/06/2019
-- Continued Progress in the OPTIC Phase 1 Clinical Trial -- Patients Receiving Single Intravitreal Injection of ADVM-022 Dosed at 2 x 10^11 vg/eye MENLO PARK, Calif., June 10, 2019 (GLOBE NEWSWIRE) -- Adverum [...]
CohBar poster available on preclinical results showing efficacy of a new family of mitochondria based therapeutics in a type 2 diabetes model as presented at the American Diabetes Association 79th Scientific Sessions
10/06/2019
In vitro data demonstrate interaction with the apelin receptor MENLO PARK, Calif., June 10, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company focused on developing mitochondria [...]
CeCors Inc. Preparing Final Stages of Launching CannMedLive App
10/06/2019
LAS VEGAS, NV, June 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CeCors, Inc. (OTC PINK: CEOS), a Company focused on the Health & Technology Sector as well as other Emerging Technologies, is pleased to update [...]
Evolus Provides Update on Nuceiva™ Marketing Authorization Application in Europe
10/06/2019
NEWPORT BEACH, Calif., June 10, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS) today provided an update on the marketing authorization application (MAA) for Nuceiva™ in Europe that may result in the European [...]
Medtronic Announces Its Forthcoming Robotic Assisted Surgical Platform to Feature Three-Dimensional Vision System from KARL STORZ
10/06/2019
Four Year Partnership Made Public Today DUBLIN - June 10, 2019 - To enable upcoming regulatory filings, Medtronic plc (NYSE:MDT) today made public its partnership with KARL STORZ SE & Co. KG (Tuttlingen, Germany), a [...]
Homology Medicines Initiates Phase 1/2 Study for HMI-102 Gene Therapy Candidate for Adults with PKU and Expects Initial Clinical Results by Year End 2019
10/06/2019
- Enrollment in the pheNIX Study Marks First Gene Therapy Clinical Trial for PKU - BEDFORD, Mass., June 10, 2019 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today [...]
Edap Tms: EDAP Announces Positive Outcome from CPT Panel for HIFU Reimbursement in the U.S.
10/06/2019
AMA allocates a new Category 1 CPT code for High Intensity Focused Ultrasound (HIFU) Definitive CPT code will cover the transrectal ablation of malignant prostate tissue with HIFU including ultrasound guidance LYON, [...]
CorMedix Inc. to Ring NYSE Closing Bell on Monday, June 10
10/06/2019
BERKELEY HEIGHTS, N.J., June 10, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment [...]
Resverlogix Announces Participation at Leading, International Scientific Conferences
10/06/2019
Supports Epigenetics Symposium during ERA-EDTA 2019 CALGARY, Alberta, June 10, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) announced today its participation at leading, [...]
Obalon Appoints Bob MacDonald as Chief Retail Officer
10/06/2019
Experienced executive with successful track record of leading strategic growth initiatives, including national chain of retail cosmetic surgery clinics SAN DIEGO, June 10, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, [...]
Sharon R. Gabrielson Named Chair of Sharps Compliance Board of Directors
10/06/2019
HOUSTON, June 10, 2019 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service national provider of comprehensive waste management solutions including medical, [...]
Mateon and Oncotelic Report on Continuing Integration of the two Businesses
10/06/2019
-Relocation of Corporate Headquarters -Introduction of Amit Shah as incoming CFO -Presentation of Integrated Pipeline at BIO2019 AGOURA HILLS, Calif., June 10, 2019 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB: [...]
Vystar Contracts Med Air Solutions to White Label ViraTech Air Purification Systems And Distribute to Medical Housing Markets, Nursing Homes and Ecuador
10/06/2019
WORCESTER, Mass., June 10, 2019 (GLOBE NEWSWIRE) -- Vystar® Corp . (OTC: VYST) and Competitive Edge Services LLC DBA Med Air Solutions (MAS) have signed an agreement whereby Med Air Solutions will white label Vystar’s [...]
Canada House Wellness Group Inc. Announces Additions to Senior Management Team
10/06/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, June 10, 2019 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE: CHV) (“ Canada House ” or the “ Company ”), a fully [...]
Innovate Biopharmaceuticals Announces the Start of the First Phase 3 Clinical Trial in Celiac Disease
10/06/2019
Launch of the first ever phase 3 trial in the history of celiac disease RALEIGH, N.C., June 10, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused [...]
HempAmericana Announces Substantial Purchase Order Agreement and New Supplier Relationship with Eagle Hemp
10/06/2019
NEW YORK, June 10, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”), an emerging leader in the CBD products market, is thrilled to announce a new Purchase [...]
Eloxx Pharmaceuticals’ Phase 2 Study of ELX-02 in Cystinosis Receives Authorization of Clinical Trial Application (CTA) by Health Canada and Funding from Genome Quebec and Genome Canada
10/06/2019
Dr. Paul Goodyer, a Professor of Pediatrics at McGill University and recognized leader in hereditary renal disease, will be the principal investigator in the Phase 2 clinical trial Genome Quebec and Genome Canada [...]

Pages